These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 13125023)

  • 1. [Distribution of Rh genotypes and irregular anti-Rh agglutinins in the Nord region of France; study of 1,000 subjects and 65 sera].
    GOUDEMAND M; ROPARTZ C
    Ann Inst Pasteur Lille; 1952-1953; 5():174-6. PubMed ID: 13125023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laboratory use of test sera containing agglutinins and blocking blood factors (anti-Rh sera)].
    PETTENKOFER HJ
    Dtsch Med J; 1954 Aug; 5(15-16):496-7. PubMed ID: 13200370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obtaining highly active anti-Rh sera by means of directed reimmunization of volunteer donors].
    Bashlaĭ AG; Verbitskiĭ MSh; Morgulis NB; Babicheva MM
    Probl Gematol Pereliv Krovi; 1977 Oct; 22(10):54-6. PubMed ID: 415302
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-Rh agglutinins in serum of Rh-negative subjects].
    DROBYSHEVA NS
    Sov Med; 1955 Feb; 19(2):52-6. PubMed ID: 14386072
    [No Abstract]   [Full Text] [Related]  

  • 5. Report on maternal sera in which Rh antibodies of anti-Rh-o(D), anti-rh'(C), anti-rh" (E), anti-hr' (c) and anti-hr" (e) specificities have acted strongly, and almost exclusively, with enzyme-treated cells.
    WHITTINGHAM S
    Med J Aust; 1962 Nov; 49(2)():744-6. PubMed ID: 14000428
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of 6 enzyme treatment protocols of hematic samples for the research of irregular agglutinins].
    Chabert C; Renier JL; Quillet P; Baufine-Ducrocq H
    Ann Biol Clin (Paris); 1997; 55(6):610-3. PubMed ID: 9499924
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo effect of ascorbic acid, cortisone and several chemical substances containing-SH radicals, upon the agglutinins, especially anti-Rh agglutinins.
    LAYRISSE M; PERES Z; AGUERO O; PITTALUGA JR
    Rev Belg Pathol Med Exp; 1955 Mar; 24(2):122-7. PubMed ID: 14385381
    [No Abstract]   [Full Text] [Related]  

  • 8. Distribution of ABO blood groups and rhesus factor in Southwest Saudi Arabia.
    Sarhan MA; Saleh KA; Bin-Dajem SM
    Saudi Med J; 2009 Jan; 30(1):116-9. PubMed ID: 19139784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rh factor in Lagos, Nigeria; report of 1,000 tests with anti-A, anti-B and anti-D sera.
    WINSTON RM
    West Afr Med J; 1954 Mar; 3(1):17-22. PubMed ID: 13169725
    [No Abstract]   [Full Text] [Related]  

  • 10. [Irregular iso-agglutinins and sensitization].
    OTTENSOOSER F
    An Paul Med Cir; 1950 Feb; 59(2):135-45. PubMed ID: 15411022
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunohematologic surveillance of the pregnant woman and the new prevention policy of anti-RH1 allo-immunization].
    Mannessier L
    Transfus Clin Biol; 2007 May; 14(1):112-9. PubMed ID: 17524695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
    Pasha RP; Bahrami ZS; Niroomanesh S; Ramzi F; Razavi AR; Shokri F
    Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the clinical utility of routine antenatal screening of pregnant women at first clinic attendance for haemoglobin genotypes, haematocrit, ABO and Rh blood groups in Port Harcourt, Nigeria.
    Jeremiah ZA
    Afr J Reprod Health; 2005 Dec; 9(3):112-7. PubMed ID: 16623195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intermittent remission of agglutination and antibody formation and irregular agglutination as sources of error in Rh/Hr and MN blood group determination].
    PIETRUSKY F
    Medizinische; 1954 Dec; 49():1636-7. PubMed ID: 13235141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Modification of conglutinating anti-Rh sera by various chemicals. V..].
    SPIELMANN W
    Z Immun exp ther; 1954 Nov; 111(5):471-84. PubMed ID: 14349077
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of polyvinylpyrrolidone for preparation of standard anti-Rh sera].
    Ashkenazi AIa
    Probl Gematol Pereliv Krovi; 1968 Dec; 13(12):49-52. PubMed ID: 4981925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preparation of anti-Rh serum].
    PICAZO GUILLEN J; MENDIVIL OZAMIZ A; DOMINGUEZ CARMONA M; GALVE BRUNENGO C
    Med Cir Guerra; 1954; 16(7-8):453-7. PubMed ID: 13202796
    [No Abstract]   [Full Text] [Related]  

  • 18. Varieties of anti-Rh agglutinins; some of their characteristics.
    DIAMOND LK; ABELSON NM
    Am J Dis Child (1911); 1947 Feb; 73(2):239. PubMed ID: 20341790
    [No Abstract]   [Full Text] [Related]  

  • 19. [An anti-D (Rho) serum obtained by immunization of Rh-negative donors].
    SANCHES VR
    An Inst Med Trop (Lisb); 1953 Jun; 10(2):211-4. PubMed ID: 13180926
    [No Abstract]   [Full Text] [Related]  

  • 20. [The ABO and Rh blood groups in France].
    KHERUMIAN R; MOULLEC J; CAGNARD JP
    Presse Med (1893); 1958 Aug; 66(57):1309-11. PubMed ID: 13578907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.